BehyarZoghiMDPhD, FACP

Oncology • San Antonio, TX

Cutaneous Lymphoma, Hematologic Oncology, Complementary and Integrative

Director of Long-term clinic at Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital

Join to view full profile

Dr. Zoghi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Zoghi's full profile

Already have an account?

Office
7700 Floyd Curl Dr
San Antonio, TX 78229
Phone+1 210-575-3817

Fax+1 210-575-4113

Summary

I am a Transplant Physician, triple board-certified in Internal Medicine, Hematology, and Medical Oncology, with over a decade of experience. I recently completed recertification in all three specialties, demonstrating my commitment to staying at the forefront of advancements in medicine and providing exceptional patient care.I currently serve as the Director of the Long-Term Clinic at Sarah Cannon Transplant and Cellular Therapy at Methodist Hospital, a position I began in April 2024. Additionally, I am part of the Adult Blood and Marrow Stem Cell Transplant Program at the Texas Transplant Institute and a member of the Sarah Cannon Blood Cancer Network, specializing in stem cell transplantation and cellular therapies for hematologic malignancies.I earned my MD and PhD from Texas A&M College of Medicine, completed my residency at UT Southwestern Medical Center/Parkland Hospital System, and pursued a fellowship in Hematology and Medical Oncology at the University of Texas Health Science Center in San Antonio. During my fellowship, I conducted innovative research on microRNA as a novel treatment for chemotherapy-resistant breast cancer, earning a patent and the Texas Society of Clinical Oncology Award. My work focuses on immunotherapy, targeted therapy, and CAR-T cell therapy, with a commitment to improving outcomes for patients with challenging malignancies.Beyond my clinical work, I am dedicated to medical education. From 2015 to 2021, I served as Chair of the Graduate Medical Education Committee at Methodist Healthcare System, enhancing training environments for fellows and residents. I am currently an Assistant Professor of Medicine at the University of Texas Health Science Center in San Antonio, mentoring the next generation of physicians. I am a Fellow of the American College of Physicians, committed to advancing cancer care, mentoring future physicians, and providing innovative treatments to my patients.

Doctor of the Year Award 2020: Behyar Zoghi MD, PhD, FACP

I am honored to be named "Doctor of the Year 2020" and to receive the Sparrow Award. Human beings are members of a whole, In creation of one essence and so...

2019 Arrival Awards: Beacon of Light - Dr. Behyar Zoghi

Dr. Behyar Zoghi was honored at the 20th Anniversary Arrival Awards with one of the Beacon of Light Awards by the University of Houston Law Center for his suppo

2019 Arrival Awards Beacons of Light

Uploaded by The University of Houston Law Center on 2019-09-03.

Methodist Healthcare: You're Family

Uploaded by SAHealth210 on 2019-06-03.

Arrival Awards 2019 Kick Off

Uploaded by The University of Houston Law Center on 2019-08-19.Arrival Award Gala celebrating immigrants' achievement. I am honored to be one of them.

Hearts Need Art brings music and visual arts to cancer patients

MDNews - San Antonio - October 2017

MDNews - San Antonio - June 2017

American College of Physicians Ceremony, San Diego 2017

ACP Convocation Ceremony held on March 30, 2017 at the San Diego Convention Center.

Education & Training

University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2008 - 2010
University of Texas Southwestern Medical CenterInternship, Internal Medicine, 2007 - 2008
Texas A&M; Health Science Center College of MedicineClass of 2007

Certifications & Licensure

TX State Medical License 2010 - 2025
CA State Medical License 2016 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Top Doctor Castle Connolly, 2021-2023
Texas Super Doctor 2019-2022
One of Top 20 Impact Maker Award Houston, Texas, 2020
Doctor of the Year Award: Sparrow Award HNA, 2020
Arrival Award: Beacon of Light 2019: recognizing the contribution of immigrants to the nation. University of Houston Law Clinic, 2019
Early Career Physician Leader of the Year Award American College of Physician: Texas Chapter (One or two Physicians are selected for each year), 2019
Texas Super Doctor: Rising Star Super Doctor, 2018-2019
Texas Super Doctor Rising Star Texas Monthly, 2018
Fellow of American College of Physicians: F.A.C.P. American College of Physicians, 2017
Patent holder regarding novel treatment in breast cancer UTHSCSA, 2017
General Internal Medicine Statewide Preceptorship Recognition Award 2017
One of four fellows awarded TSCO award in the State of Texas Texas Society of Clinical Oncology (TSCO), 2012
CIPRIT grant x 2 years Cancer Prevention Research Institute of Texas, 2011-2013
One of 16 fellows selected at bone marrow transplant 2nd Annual meeting 2nd annual meeting of Future of bone marrow transplant fellows, 2013
First place award in 7th Graduate Student Research Symposium Texas A&M University, 1997
Teaching Excellent Award University of Houston
Join now to see all

Clinical Trials

A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients Start of enrollment: 2013 Aug 01
Completed
Phase 3
Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) Start of enrollment: 2014 Aug 01
Completed
Phase 2
A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease Start of enrollment: 2016 Sep 15
Completed
Phase 2
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy Start of enrollment: 2018 Oct 11
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

78 citations
ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease.
Madan Jagasia, Aleksandr Lazaryan, Carlos Bachier, Amandeep Salhotra, Daniel J. Weisdorf
Journal of Clinical Oncology. 2021-04-20
136 citations
Belumosudil for Chronic Graft-versus-Host Disease (cGVHD) After 2 or More Prior Lines of Therapy: The ROCKstar Study
Corey Cutler, Stephanie J. Lee, Sally Arai, Marcello Rotta, Behyar Zoghi
Blood. 2020-11-05
Primary Cutaneous Diffuse Large B-Cell Lymphoma of the Upper Limb: Double Hit/Double Expressor with CNS Involvement: From Hospice to Remission.
Brenda S Castillo, Maria L Rodriguez, Ju-Hsien John Chao, Behyar Zoghi
Case Reports in Hematology. 2019-02-07

Journal Articles

Primary Cutaneous Diffuse Large B Cell Lymphoma of the Upper Limb: Double Hit/Double Expressor with CNS involvement: from Hospice to Remission
Brenda S. Castillo B.S., Maria Rodriguez, Ju-Hsien John Chao, DO, & Behyar Zoghi, MD, PhD, FACP, Case Reports in Hematology, 2/7/2019
Spontaneous Resolution of Multiple Hyperpigmented Lesions with Platelet Transfusion
Brenda S. Castillo & Behyar Zoghi, International Journal of Clinical & Medical Images, 12/10/2018
Endocrine therapy for Leptomeningeal Metastases from ER-positive Breast cancer: Case Report and a Review of Literature
Behyar Zoghi M.D., Ph.D., and Richard Elledge M.D., The Breast Journal, 1/8/2016
Treatment of Acquired Von-Willebrand Syndrome (AVWS) and Prevention of Bleeding Post Autologous Stem Cell Transplant (ASCT) during Severe Pancytopenia with IVIG
Behyar Zoghi, M.D., Ph.D.,Paul Shaughnessy M.D , Roger M. Lyons M.D., Richard Helmer M.D., Calos Bachier M.D., & Frederick LeMaistre M.D.., Case Reports in Hematology, 3/20/2015
Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine
Hein TW,Wang W, Zoghi B, Muthuchamy M, Kuo L., J Mol cell Cardiology. 2001 Feb;33(2):271-82
The involvement of tyrosine kinases, cyclic AMP/protein kinase A and p38 mitogen-activated protein kinase in IL-13-mediated arginase I induction in macrophages
Chang CI, Zoghi B, Liao JC, Kuo L, J immunology
Join now to see all

Abstracts/Posters

KD025 for Patients with Chronic Graft-Versus-Host Disease (cGVHD) _ Long-Term Follow-up of a Phase 2a Study (KD025-208)
Behyar Zoghi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Improving the efficacy if chemotherapy drugs for the treatment of triple-negative breast cancer
Zoghi B, Ravdin P, Journal of Clinical Oncology
MicroRNAs as novel therapeutic targets to treat drug-resistant breast cancer
Chang YF, Zoghi B, Panneerdoss S, Pertsemlidis A, Rao MK, AACR annual meeting
Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor for Relapse After Allogeneic Stem Cell Transplantation
Zoghi B, Paul J. Shaughnessy,Cesar De Las Casas; Ka Wah Chan;Veronica H Jude; Robert Sanders; Ashley Simpson; Jill MacPherson; Lisa McDonald; Julie Luke; and Carlos Ba..., BMT Tandem Meeting, Bone marrow trasnplant, Salt Lake City, Utah
Join now to see all

Press Mentions

Hearts Need Art Brings Music and Visual Arts to Cancer PatientsJuly 20th, 2018
New Hope for Taming Triple-Negative Breast CancerOctober 2nd, 2012
www.drzoghi.comDecember 19th, 2022

Committees

American College of Physician, Medical Student Committee Member 2019 - Present
Member, Clinical Peer Review Committee at Methodist Healthcare System 2015 - Present
Chairman, Graduate Medical Education at Methodist HealthCare System 2015 - 2021
Medical Oncologist, Cancer Committee Member at Methodist Hospital 2014 - 2021